Cargando…
Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
BACKGROUND: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the mem...
Autores principales: | Pericàs, Juan M., Bromberg, Daniel J., Ocampo, Denise, Schatz, Eberhard, Wawer, Iwona, Wysocki, Piotr, Safreed-Harmon, Kelly, Lazarus, Jeffrey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429787/ https://www.ncbi.nlm.nih.gov/pubmed/30898122 http://dx.doi.org/10.1186/s12954-019-0290-x |
Ejemplares similares
-
Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future
por: O’Gorman, Aileen, et al.
Publicado: (2021) -
HMAP, World Hepatitis Day and the bigger health systems picture
por: Lazarus, Jeffrey V., et al.
Publicado: (2016) -
Harm reduction in Europe: a framework for civil society-led monitoring
por: Rigoni, Rafaela, et al.
Publicado: (2021) -
Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)
por: Lazarus, Jeffrey V., et al.
Publicado: (2016) -
Production losses associated with premature mortality in 28 European Union countries
por: Łyszczarz, Błażej
Publicado: (2019)